WHO vaccine-preventable diseases: monitoring system. 2017 global summary

Last updated 15-July-2017 (data as of 11-July-2017)
Next overall update Fall-2017
EPI mother and child logo         
Select a country

Development status: Least developed GNI / capita (US$): 1 Infant (under 12 months) mortality rate: 352
GDP / capita (US$): 1 Child (under 5 years) mortality rate: 472

Population data in thousands3

  2016  2015  2014  2013  2012  2000  1990  1980 
Total population 200  196  191  187  183  139  114  95 
Births
Surviving infants
Pop. less than 5 years 31  31  31  30  30  23  20  19 
Pop. less than 15 years 86  85  84  82  80  62  54  45 
Female 15-49 years 47  46  45  44  43  32  23  19 

Number of reported cases

(Click for retrospective incidence data for Sao Tome and Principe)
Diphtheria
ChartChart
 
Japanese encephalitis
 
Measles
ChartChart ChartChart
  10  519 
Mumps
ChartChart
 
Pertussis
ChartChart
 
Polio*
ChartChart
 
Rubella
ChartChart
 
Rubella (CRS)
ChartChart
 
Tetanus (neonatal)
ChartChart
 
Tetanus (total)**
ChartChart
  12 
Yellow fever
 
* Polio refers to all polio cases (indigenous or imported), including polio cases caused by vaccine derived polio viruses (VDPV). For disaggregated data please click on this hyperlink: https://extranet.who.int/polis/public/CaseCount.aspx
it does not include cases of vaccine-associated paralytic polio (VAPP) and cases of non polio acute flaccid paralysis [AFP]).
** Neonatal Tetanus and Total Tetanus cases equality may be the result from a lack of non-Neonatal Tetanus surveillance system.

Percentage target population vaccinated by antigen

Hovering over an antigen reveals its fuller definition
  Most recent coverage survey4  

Official country estimates5

  (Click for retrospective coverage estimates data for Sao Tome and Principe)
Vaccine year result method % card seen                                                
BCG 2012  97  MICS   92  92  97  95  97  99  81  99* 
DTP1 2012  97  MICS   92  97  98  98  99*  98 
DTP3 2012  95  MICS   92  96  96  95  97  96  82  92 
DTP4         
IPV1          90 
HepB_BD          84  91  95 
HepB3 2012  95  MICS   92  96  96  95  97  96 
Hib3 2012  95  MICS   92  96  96  95  97  96 
JapEnc         
MCV1          93  93  92  91  92  69  71 
MCV2          76  76  71 
MenA         
PCV1          97  98  98  99  64 
PCV2          97  97  96  98 
PCV3 2012  85  MICS   92  96  96  95  97 
Pol3 2012  90  MICS   92  96  96  95  97  96  87  90 
Rota1          99 
RotaC          54 
RCV1         
TT2plus 2013  55  MICS   92  89  92  91  90  92  75  65 
PAB          95  96  95  97  99 
VAD1          80  90  83  78  91 
YFV 2012  90  MICS   92  93  93  92  91  92 
* indicates the country reported above 100% coverage.

  Next update: Mid-July 2018

WHO-UNICEF estimates6

  (Click for full retrospective WHO-UNICEF coverage estimates data for Sao Tome and Principe)
BCG
ChartChart
  92  97  95  97  99  81  99 
DTP1
ChartChart
  97  98  98  99  98  89  97 
DTP3
ChartChart
  96  96  95  97  96  82  92 
HepB3
ChartChart
  96  96  95  97  96 
HepB_BD
ChartChart
 
Hib3
ChartChart
  96  96  95  97  96 
IPV1
  67 
MCV1
ChartChart
  93  93  92  91  92  69  71 
MCV2
ChartChart
  76  76  71 
PCV3
ChartChart
  96  96  95  97 
Pol3
ChartChart
  96  96  95  97  96  87  90 
RCV1
ChartChart
  93 
RotaC
ChartChart
  24 
YFV
ChartChart
  91  92 

Click for WHO-UNICEF coverage estimates data for PAB time series.

Number of districts in the country Proportion of
districts reporting
DTP3 coverage:
% of coverage reports received at national
level vs number of reports expected
100 
   
/
|
|
\
Greater or equal to 90% 100
From 80 to 89% 0
From 50 to 79% 0
Less than 50% 0
Proportion of districts
not reporting DTP3 coverage
0
DTP3 reported coverageDTP3 reported coverage

Immunization Schedule (2016 or latest available)

Hovering over an antigen reveals its fuller definition
Vaccine Schedule Entire country Comment
BCG birth; Yes
DTwPHibHepB 6, 10, 14 weeks; Yes
HepB birth; Yes HepB positive mothers
HPV 10 years; Yes From October 2017
IPV 14 weeks; Yes
Measles 9, 18 months; Yes
MR 9, 18 months; Yes
OPV birth; 6, 10, 14 weeks; 18 months; Yes
Pneumo_conj 6, 10, 14 weeks; Yes
Rotavirus 6, 10, 14 weeks; Yes
Td 1st contact; +1, +6 months; +1, +2 years; Yes Pregnant women
VitaminA 6, 12, 18, 24, 30, 36 months; Yes and postpartum
YF 9 months; Yes

Immunizaton indicators

Indicator Expected answer 2016  2015  2014  2013  2012  2011  2010 

Planning and management

Has the country a Multi-Year Plan (MYP) for immunization? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 
What years does the MYP cover? number 2016-2020  2016-2020  2012-2016  2012-2016  2012-2016  2012-2016  2008-2012 
Nº of districts with microplans that include activities to raise immunization coverage number

System performance

Total Nº districts in country number
Nº districts with DTP3 coverage >=80% number
% of districts with DTP3 coverage >=80% From 0 to 100% 100  100  100  100  100  100  100 
Nº districts with measles (MCV1) coverage >=95% number
% of districts with MCV1 coverage >=95% From 0 to 100% 57  71  43  29  43 

Safety

Has the country a vaccine adverse events review committee? Yes/No/NR/ND Yes  Yes  Yes  Yes  Yes  No  No 
Is there a national system to monitor adverse events following immunization (AEFI)? Yes/No/NR Yes  Yes  Yes  Yes  Yes  No  Yes 

Finance

% of Immunization expenditure financed, using Government funds? From 0 to 100% 65  75  77  89  75  84  83 

National Immunization Advisory Mechanism

Has the country a standing technical advisory group on immunization (NITAG)? Yes/No/NR No  No  No  No  No  Yes  No 

Sources

 1  "The 2017 World Bank Development Indicators Online", GDP per capita is PPP adjusted.
 2  World Health Statistics 2016, data for 2015
 3  "United Nations, Population Division. The World Population Prospects - the 2017 revision". New York, 2017.
 4  UNICEF/WHO survey database
 5  If no official estimate is available, the administrative coverage is reported. '*' indicates coverage over 99.5%.
 6  WHO-UNICEF estimates.